Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse (Q34631254)

3 August 2017

Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse (English)

1 reference

3 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Gianluigi Tanda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

author name string

Maria Scherma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Liana Fattore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Jessica Stroik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Carrie Wertheim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Walter Fratta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

Steven R Goldberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

language of work or name

English

0 references

publication date

1 May 2007

1 reference

3 August 2017

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

page(s)

5615-5620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies

16 May 2020

cites work

1 reference

12 December 2020

alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release

1 reference

12 December 2020

Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

1 reference

12 December 2020

Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice.

1 reference

12 December 2020

Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo

1 reference

12 December 2020

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

1 reference

12 December 2020

Synaptic plasticity and nicotine addiction

1 reference

12 December 2020

The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.

1 reference

12 December 2020

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

12 December 2020

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

1 reference

12 December 2020

Endocannabinoids in cognition and dependence

1 reference

12 December 2020

Cellular and synaptic mechanisms of nicotine addiction

1 reference

12 December 2020

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction

1 reference

12 December 2020

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

1 reference

12 December 2020

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

12 December 2020

Nicotine as a modulator of behavior: beyond the inverted U.

1 reference

12 December 2020

Acetylcholine modulation of neural systems involved in learning and memory

1 reference

12 December 2020

Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action.

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain

1 reference

12 December 2020

Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist

1 reference

12 December 2020

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

1 reference

12 December 2020

The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice

1 reference

12 December 2020

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

1 reference

12 December 2020

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization

1 reference

12 December 2020

The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice

1 reference

12 December 2020

Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area

1 reference

12 December 2020

Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors

1 reference

12 December 2020

Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.

1 reference

12 December 2020

Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release.

1 reference

12 December 2020

Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.

1 reference

12 December 2020

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

1 reference

12 December 2020

Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration.

1 reference

12 December 2020

Cannabinoid self-administration increases dopamine release in the nucleus accumbens.

1 reference

12 December 2020

Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system

1 reference

12 December 2020

Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.

1 reference

12 December 2020

Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

1 reference

12 December 2020

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

1 reference

12 December 2020

A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain.

1 reference

12 December 2020

Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.

1 reference

12 December 2020

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

12 December 2020

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

1 reference

12 December 2020

Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells

1 reference

12 December 2020

10.1523/JNEUROSCI.0027-07.2007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6672748&resulttype=core&format=json

16 May 2020

1 reference